BHEIX
Price
$29.08
Change
+$0.11 (+0.38%)
Updated
Jul 3 closing price
Net Assets
1.88B
PRRCX
Price
$12.40
Change
+$0.05 (+0.40%)
Updated
Jul 3 closing price
Net Assets
129.62M
Interact to see
Advertisement

BHEIX vs PRRCX

Header iconBHEIX vs PRRCX Comparison
Open Charts BHEIX vs PRRCXBanner chart's image
BlackRock High Equity Income K
Price$29.08
Change+$0.11 (+0.38%)
VolumeN/A
Net Assets1.88B
Victory Pioneer Equ Premium Income C
Price$12.40
Change+$0.05 (+0.40%)
VolumeN/A
Net Assets129.62M
BHEIX vs PRRCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BHEIX vs. PRRCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHEIX is a StrongBuy and PRRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHEIX has more cash in the bank: 1.88B vs. PRRCX (130M). PRRCX pays higher dividends than BHEIX: PRRCX (10.86) vs BHEIX (8.12). BHEIX was incepted earlier than PRRCX: BHEIX (5 years) vs PRRCX (15 years). PRRCX (2.14) is less costly to investors than BHEIX (0.88). PRRCX is a more actively managed with annual turnover of: 114.00 vs. BHEIX (85.00). PRRCX has a lower initial minimum investment than BHEIX: PRRCX (1000) vs BHEIX (5000000). PRRCX (11.17) and BHEIX (11.13) have marching annual gain over last year. BHEIX return over 5 years is better than : 82.77 vs. PRRCX (33.11).
BHEIXPRRCXBHEIX / PRRCX
Total Expense Ratio0.802.1437%
Annual Report Gross Expense Ratio0.882.1441%
Fund Existence5 years15 years-
Gain YTD8.73610.54083%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.88B130M1,446%
Annual Yield % from dividends8.1210.8675%
Returns for 1 year11.1311.17100%
Returns for 3 years33.6428.78117%
Returns for 5 years82.7733.11250%
Returns for 10 yearsN/A17.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX41.250.42
+1.03%
Patient Opportunity A
TARKX30.490.31
+1.03%
Tarkio
MMMPX24.740.14
+0.57%
Morgan Stanley Inst Emerging Mkts R6
VGIFX88.660.48
+0.54%
JPMorgan US Value R5
EILAX14.01-0.02
-0.14%
Eaton Vance International Small-Cap A